Stanford University
Showing 71-80 of 380 Results
-
Julia D. Ransohoff
Instructor, Medicine - Oncology
BioDr. Ransohoff received her B.A. from Harvard College in Human Developmental and Regenerative Biology and completed her medical training at Stanford University, where she received her M.D., completed residency in internal medicine, and fellowship training in hematology and oncology as part of the American Board of Internal Medicine Physician Scientist Training Program.
Dr. Ransohoff is a physician-scientist dedicated to improving breast cancer treatments and outcomes through developing genomic methods to profile how tumors respond to treatment. Her research focuses on molecular approaches to understand the variable clinical responses of breast cancers to treatment at the genomic level by profiling molecular residual disease. Her current work involves exploring mechanisms of chemoresistance and immune evasion and identifying novel therapeutic targets. In related work, she also studies epidemiological risk factors for breast cancer mortality with a focus on the gut microbiome, oncofertility, and racial and ethnic differences in treatment response. Dr. Ransohoff's research has been supported by the ASCO Conquer Cancer Foundation, the Terri Brodeur Breast Cancer Foundation, the Stanford Cancer Institute, ECOG-ACRIN, and the Chan Zuckerberg Initiative.
As an Instructor in the Division of Medical Oncology, Dr. Ransohoff is also a clinically active oncologist, treating patients with breast cancer. -
Anoop Rao
Assistant Professor of Pediatrics (Neonatology)
Current Research and Scholarly InterestsWearable senors, unobtrusive vital sign monitoring, natural language processing/text mining
-
Jianghong Rao
Professor of Radiology (Molecular Imaging Program at Stanford) and, by courtesy, of Chemistry
Current Research and Scholarly InterestsProbe chemistry and nanotechnology for molecular imaging and diagnostics
-
Mitesh Rao
Adjunct Clinical Assistant Professor, Emergency Medicine
BioDr. Mitesh B. Rao, MD, MHS is the Founder and CEO of OMNY, a venture-backed company revolutionizing how healthcare data is shared and valued. A Board-Certified Emergency Medicine Physician, Dr. Rao practices clinically as an Assistant Professor of Emergency Medicine at Stanford. Most recently, he served as the Chief Patient Safety Officer for Stanford Healthcare where he led Patient Safety, Quality, and System Redesign for the Enterprise. Dr. Rao also served as Director of the Center for Advancing Patient Safety (CAPS), which focused on advancing the science and implementing new innovations in the fields of Patient Safety and Quality Improvement.
Previously, he was trained in leadership and research skills as a Fellow in the prestigious Robert Wood Johnson Clinical Scholars Program. Subsequent to his time at Yale, he served as the Director of the Patient Safety Education Program at Northwestern Medicine. As a physician leader, he was helped implement systems-level improvements for quality and safety in institutions across the country and overseas that have had lasting effects on patient care provision. He has also led teams serving contracts with various governmental and non-profit agencies such as the Joint Commission Resources, CMS, the Canadian Patient Safety Institute, Partners Health Care, and the American College of Surgeons in multiple campaigns and initiatives to improve Patient Safety on a national level.
Dr. Rao also served as the Head of Research and Integration for the health innovation program at Northwestern. In this role, he developed an expertise in improving care provision through innovative methodologies. He spearheaded efforts to integrate innovative technologies into the health system to improve patient care in a variety of settings, including telemedicine and mHealth initiatives. Working both with innovators and researchers across the various schools of the University as well as promising startups from around the country, Dr. Rao helped guide and refine the process for vetting and integrating pilot programs to test new technologies within the clinical venue. He also serves as a mentor to multiple healthcare-focused startups and accelerator groups across the country in order to help guide the development of implementation of innovative solutions that can sustainably impact patient care provision. -
Yuan James Rao, MD
Associate Professor of Radiation Oncology (Radiation Therapy)
BioDr. Yuan James Rao is an Associate Professor of Radiation Oncology, and Co-Director of Proton Therapy at Stanford University. In 2026, Dr. Rao co-led the team at Stanford that treated the world’s first pediatric and adult patients with ultra-compact upright proton therapy. Dr. Rao’s professional goal is to develop the world’s most advanced proton therapy program at Stanford University.
Proton therapy is a remarkable form of radiation treatment that uses heavy charged particles (protons) accelerated to approximately two-thirds the speed of light. The unique physics of protons allows the radiation to stop within a defined distance in the body, whereas standard x-ray therapy continues to deposit radiation after treating the tumor (known as “exit dose”). By reducing exit dose, protons may reduce normal tissue exposure to radiation, which is particularly beneficial for children and young adults with cancer, and patients requiring a second course of radiation. Dr. Rao currently coordinates the Stanford Radiation Oncology Department’s clinical, research, and education efforts related to proton therapy.
Dr. Rao’s clinical practice focuses on the care of patients with Head and Neck cancer, and Thoracic cancers. His goal is to provide the highest quality care to his patients, using the most appropriate technology. This may include proton therapy but also potentially other techniques such as intensity modulated radiation therapy (IMRT), stereotactic body radiation (SBRT), MR-guided radiotherapy, 3D conformal radiotherapy, or other technologies. Nearly all radiation technologies are available at Stanford University, and thus Dr. Rao and his Radiation Oncology colleagues are well positioned to choose the best treatment for every patient.
Dr. Rao trained at the prestigious Mallinckrodt Institute of Radiology at Washington University in St. Louis, and during residency was among the first physicians in the world to use the Mevion S250 proton therapy device and the ViewRay MRI-guided radiotherapy device. Dr. Rao has traveled to UCSF, MD Anderson, Johns Hopkins University, University of Pennsylvania, Medical University of Vienna, and University Medical Center Utrecht to learn about various advanced radiotherapy techniques including MR-guided radiotherapy, brachytherapy, and proton therapy.
Prior to his role at Stanford, Dr. Rao was a physician at George Washington University in Washington, DC and held the positions of Associate Professor of Radiation Oncology and Biomedical Engineering (by courtesy), and Assistant Professor of Neurosurgery (by courtesy). He was also the founding Director of Brachytherapy, and implemented programs for gyn, head and neck, prostate, and skin radiation implants using high dose rate (HDR) techniques. He was honored as a Washingtonian Top Doctor for each of the years that he practiced in DC, and Dr. Rao has treated members of Congress with radiotherapy (public information).
Dr. Rao is a prolific researcher with more than 50 peer-reviewed publications. He is an expert in proton therapy, head and neck cancer, thorax cancers, gyn cancers, GU cancers, brachytherapy, artificial intelligence, machine learning, image analysis and large database "big data." He is co-author of the ‘Endometrial Cancer’ chapter of the 8th edition of Perez and Brady’s Principles and Practice of Radiation Oncology, the world’s most widely used reference textbook in the field. He regularly gives invited talks nationally and internationally. Dr. Rao has been grant funded by the American Cancer Society.
Dr. Rao is a respected educator and mentor, and has taught numerous engineering/physics students, medical students and residents; many of whom have gone on to become successful physicists, scientists, entrepreneurs, and physicians. -
Vaughn Rasberry
Associate Professor of English and of African and African American Studies
BioVaughn Rasberry studies African American literature, global Cold War culture, the European Enlightenment and its critics, postcolonial theory, and philosophical theories of modernity. As a Fulbright scholar in 2008-09, he taught in the American Studies department at the Humboldt University Berlin and lectured on African American literature throughout Germany. His current book project, Race and the Totalitarian Century, questions the notion that desegregation prompted African American writers and activists to acquiesce in the normative claims of postwar liberalism. Challenging accounts that portray black cultural workers in various postures of reaction to larger forces--namely U.S. liberalism or Soviet communism--his project argues instead that many writers were involved in a complex national and global dialogue with totalitarianism, the defining geopolitical discourse of the twentieth century.
His article, "'Now Describing You': James Baldwin and Cold War Liberalism," appears in an edited volume titled James Baldwin: America and Beyond (University of Michigan Press, 2011). A review essay, "Black Cultural Politics at the End of History," appears in the winter 2012 issue of American Literary History. An article, "Invoking Totalitarianism: Liberal Democracy versus the Global Jihad in Boualem Sansal's The German Mujahid," appears in the spring 2014 special issue of Novel: a Forum on Fiction. For Black History Month, he published an op-ed essay, "The Shape of African American Geopolitics," in Al Jazeera English.
An Annenberg Faculty Fellow at Stanford (2012-14), he has also received fellowships from the Schomburg Center for Research in Black Culture and the Humanities Center at the University of Pittsburgh.
Vaughn also teaches in collaboration with the Center for Comparative Studies in Race and Ethnicity (CCSRE) and the programs in Modern Thought and Literature, African and African American Studies, and American Studies.
